Faculty/Staff Highlight

Predicting success of chemotherapy in breast cancer patients

Robert Wesolowski, MD, received a Davis/Bremer Pilot Award from The Ohio State University Center for Clinical and Translational Science for his research on myeloid derived suppressor cells (MDSC) in breast cancer patients receiving neoadjuvant chemotherapy.

Wesolowski is evaluating whether MDSC can predict which patients will respond well to neoadjuvant chemotherapy.

Recent Citations

Jaremka LM, Peng J, Bornstein R, Alfano CM, Andridge RR, Povoski SP, Lipari AM, Agnese DM, Farrar WB, Yee LD, Carson WE, Kiecolt-Glaser JK
Ma Y, Wei Y, Zhang X, Zhang Y, Cai H, Zhu Y, Shilo K, Oglesbee M, Krakowka S, Whelan SP, Li J
Katz ML, Young GS, Reiter PL, Battaglia TA, Wells KJ, Sanders M, Simon M, Dudley DJ, Patierno SR, Paskett ED